From brewery to pharma: Brewer's yeast engineered to produce therapeutic peptides
Scientists have developed an innovative method to produce and rapidly analyze a vast array of macrocyclic peptides, molecules increasingly used in modern medicine. The research, published in Nature Communications, harnesses the familiar brewer's yeast, turning billions of these tiny organisms into miniature fluorescent factories, each capable of creating a unique peptide with potential therapeutic applications. The team includes researchers from Ca' Foscari University of Venice, in collaboration with researchers from Japan, China, Switzerland, and Italy.
Scientists have developed an innovative method to produce and rapidly analyze a vast array of macrocyclic peptides, molecules increasingly used in modern medicine. The research, published in Nature Communications, harnesses the familiar brewer's yeast, turning billions of these tiny organisms into miniature fluorescent factories, each capable of creating a unique peptide with potential therapeutic applications. The team includes researchers from Ca' Foscari University of Venice, in collaboration with researchers from Japan, China, Switzerland, and Italy.
